Types of obesity and their impact on long-term outcomes in patients with cardiovascular disease
https://doi.org/10.14341/omet12367
Abstract
Large prospective studies involving several hundred thousands to several million people from the general population have shown that people with obesity have a higher overall mortality rate than people with a normal BMI. The use of BMI in predicting the prognosis of people with cardiovascular disease has led to the inverse relationship between BMI and risk of death. Obesity, determined by BMI, is very heterogeneous in determining prognosis in different groups of patients. The use of imaging techniques during the examination revealed that poor health effects are associated with the accumulation of visceral adipose tissue. New evidence also suggests that ectopic deposition of fat (in the liver, in the epicardium) may increase the risk of developing atherosclerosis and cardiovascular disease and type 2 diabetes. The number of studies examining the direct effect of visceral adipose tissue on mortality is very limited. Their results are extremely contradictory, based not on prospective observations, but on the construction of statistical models. Adipose tissue is currently considered as an endocrine and paracrine organ. Deposition of adipose tissue in the internal organs, in addition to metabolic disorders), probably leads to the formation of local adverse effects. The above data lead us to the conclusion that it is necessary to create a new classification that would improve the stratification of the risk of developing cardiovascular disease and death in people with obesity.
About the Authors
S. V. Miklishanskaya
Russian Medical Academy of Continuous Professional Education
Russian Federation
Competing Interests:
Russian Federation
Sofia V. Miklishanskaya, MD, PhD; Researcher ID: AAJ-6522-2020; Scopus Author ID: 55672897400; eLibrary SPIN: 2843-1855
3rd Cherepkovskaya 15A, 121552 Moscow
Competing Interests:
No conflict interests
N. A. Mazur
Russian Medical Academy of Continuous Professional Education
Russian Federation
Competing Interests:
Russian Federation
Nikolaу A. Mazur, MD, PhD, Professor; Scopus Author ID: 56383512500; eLibrary SPIN: 2391-0976
Moscow
Competing Interests:
No conflict of interest
References
1. Dedov II, Mel’nichenko GA, Shestakova MV, et al. Russian national clinical recommendations for morbid obesity treatment in adults. 3rd revision (Morbid obesity treatment in adults). Obesity and Metabolism. 2018;15(1):53-70. (In Russ.). doi: https://doi.org/10.14341/omet2018153-70
2. World Health Organization. Global Health Risks: mortality and burden of disease attributable to selected major risks. 2009. Available from: http://www.who.int/healthinfo/global_burden_disease/global_health_risks/en/index.html
3. Abarca-Gómez L, Abdeen ZA, Hamid ZA, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128•9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627-2642. doi: https://doi.org/10.1016/S0140-6736(17)32129-3
4. World Health Organization. What are the health consequences of being overweight? 2013. Available from: https://www.who.int/features/qa/49/ru/
5. Yumuk V, Tsigos C, Fried M, et al. European Guidelines for Obesity Management in Adults. Obes Facts. 2015;8(6):402-424. doi: https://doi.org/10.1159/000442721.
6. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994;89(3):1333-1445. doi: https://doi.org/10.1161/01
7. Pyorala K, Debacker G, Graham I, et al. Prevention of coronary heart disease in clinical practice: recommendations of the task force of the European Society of cardiology, European atherosclerosis Society and European society of Hypertension. Atherosclerosis. 1994;110(2):121-161. doi: https://doi.org/10.1016/0021-9150(94)90200-3
8. Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-Specific Excess Deaths Associated With Underweight, Overweight, and Obesity. JAMA. 2007;298(17):2028-2037. doi: https://doi.org/10.1001/jama.298.17.2028
9. Pischon T, Boeing H, Hoffmann K., et al. General and abdominal adiposity and risk of death in Europe. N. Engl. J. Med. 2008,359:2105-2120. doi: https://doi.org/10.1056/NEJMoa0801891.
10. Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083-1096. doi: https://doi.org/10.1016/S0140-6736(09)60318-4
11. Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363(23):2211-2219. doi: https://doi.org/10.1056/NEJMoa1000367
12. Orpana HM, Berthelot JM, Kaplan MS, et al. BMI and mortality: results from a national longitudinal study of Canadian adults. Obesity. 2010;18(1):214–218. doi: https://doi.org/10.1038/oby.2009.191
13. Snijder MB, van Dam RM, Visser M, Seidell JC. What aspects of body fat are particularly hazardous and how do we measure them? Int J Epidemiol. 2006; 35(1):83–92. DOI: 10.1093/ije/dyi253.
14. Lavie CJ, McAuley PA, Church TS, et al. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J AmCollCardiol. 2014;63:1345-1354. doi: https://doi.org/10.1016/j.jacc.2014.01.022
15. Miklishanskaya SV, Mazur NA, Solomasova LV, Chigineva VV. Evidence Based Obesity Paradox. J Card Disord Therapy. 2019;102:2.
16. Romero-Corral A., Somers V.K., Sierra-Johnson J. et al. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes. 2008;32(6):959-966. doi: https://doi.org/10.1038/ijo.2008.11
17. Wang S, Ren J. Executive Summary of the Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Arch Intern Med. 1998;158(17):1855-1867. doi: https://doi.org/10.1001/archinte.158.17.1855
18. Koster A, Leitzmann MF, Schatzkin A, et al. Waist Circumference and Mortality. Am J Epidemiol. 2008;167(12):1465-1475. doi: https://doi.org/10.1093/aje/kwn079
19. Visscher T, Seidell J, Molarius A, et al. A comparison of body mass index, waist–hip ratio and waist circumference as predictors of all-cause mortality among the elderly: the Rotterdam study. Int J Obes. 2001;25(11):1730-1735. doi: https://doi.org/10.1038/sj.ijo.0801787
20. Simpson JA, MacInnis RJ, Peeters A, et al. A Comparison of Adiposity Measures as Predictors of All-cause Mortality: The Melbourne Collaborative Cohort Study. Obesity. 2007;15(4):994-1003. doi: https://doi.org/10.1038/oby.2007.622
21. Cerhan JR, Moore SC, Jacobs EJ, et al. A Pooled Analysis of Waist Circumference and Mortality in 650,000 Adults. Mayo Clin Proc. 2014;89(3):335-345. doi: https://doi.org/10.1016/j.mayocp.2013.11.011
22. Cho GJ, Yoo HJ, Hwang SY, et al. Differential relationship between waist circumference and mortality according to age, sex, and body mass index in Koreans with age of 30–90 years; a nationwide health insurance database study. BMC Med. 2018;16(1):131. doi: https://doi.org/10.1186/s12916-018-1114-7
23. Coutinho T, Goel K, Corrêa de Sá D, et al. Central Obesity and Survival in Subjects With Coronary Artery Disease. J Am Coll Cardiol. 2011;57(19):1877-1886. doi: https://doi.org/10.1016/j.jacc.2010.11.058
24. Wang Y, Rimm EB, Stampfer MJ, et al. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr. 2005;81(3):555-563. doi: https://doi.org/10.1093/ajcn/81.3.555
25. Carey VJ, Walters EE, Colditz GA, et al. Body Fat Distribution and Risk of Non-Insulin-dependent Diabetes Mellitus in Women: The Nurses’ Health Study. Am J Epidemiol. 1997;145(7):614-619. doi: https://doi.org/10.1093/oxfordjournals.aje.a009158
26. Snijder MB, Zimmet PZ, Visser M, et al. Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study. Int J Obes. 2004;28(3):402-409. doi: https://doi.org/10.1038/sj.ijo.0802567
27. Canoy D. Distribution of body fat and risk of coronary heart disease in men and women. Curr. Opin. Cardiol. 2008;23:591-598. doi: https://doi.org/10.1097/HCO.0b013e328313133a
28. Neeland IJ, Poirier P, Després JP. Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management. Circulation. 2018;137:1391-1406 doi: https://doi.org/10.1161/CIRCULATIONAHA.117.029617
29. Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;143(21). doi: https://doi.org/10.1161/CIR.0000000000000973
30. Neeland IJ, Ross R, Despres JP, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7:715-725. doi: https://doi.org/10.1016/S2213-8587(19)30084-1
31. Ashwell M, Cole TJ, Dixon AK. Obesity: new insight into the anthropometric classification of fat distribution shown by computed tomography. BMJ. 1985;290(6483):1692-1694. doi: https://doi.org/10.1136/bmj.290.6483.1692
32. Nazare J-A, Smith J, Borel A-L, et al. Usefulness of Measuring Both Body Mass Index and Waist Circumference for the Estimation of Visceral Adiposity and Related Cardiometabolic Risk Profile (from the INSPIRE ME IAA Study). Am J Cardiol. 2015;115(3):307-315. doi: https://doi.org/10.1016/j.amjcard.2014.10.039
33. Druzhilov MA, Druzhilova OYu, Beteleva YuE, Kuznetsova TYu. Obesity as cardiovascular risk factor: accent on quality and functional activity of adipose tissue. Russian Journal of Cardiology. 2015;20(4):111-117. (In Russ.). doi: https://doi.org/10.15829/1560-4071-2015-04-111-117
34. Cuthbertson DJ, Steele T, Wilding JP, et al. What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications? Int J Obes (Lond). 2017;41:853-865. doi: https://doi.org/10.1038/ijo.2017.4
35. Taylor R, Holman RR. Normal weight individuals who develop type 2 diabetes: the personal fat threshold. ClinSci (Lond). 2015;128:405-410. doi: https://doi.org/10.1042/CS20140553
36. Després JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012;126:1301–1313. doi: https://doi.org/10.1161/CIRCULATIONAHA.111.067264
37. Scaglione R, Di Chiara T, Cariello T, Licata G. Visceral obesity and metabolic syndrome: two faces of the same medal? Intern Emerg Med. 2010;5(2):111-119. doi: https://doi.org/10.1007/s11739-009-0332-6
38. Kuk JL, Katzmarzyk PT, Nichaman MZ, et al. Visceral fat is an independent predictor of all-cause mortality in men. Obesity. 2006;14:336-341. doi: https://doi.org/10.1038/oby.2006.43
39. Koster A, Murphy RA, Eiriksdottir G, et al. Fat distribution and mortality: The AGES-Reykjavik study. Obesity. 2015;23(4):893-897. doi: https://doi.org/10.1002/oby.21028
40. Brown JC, Harhay MO, Meera N. Visceral Adipose Tissue Dysfunction and Mortality among a Population-Based Sample of Males and Females. Diabetes Metab. 2016;42(5):382-385. doi: https://doi.org/10.1016/j.diabet.2016.05.001
41. Balcer B, Dykun I, Schlosser T, et al. Pericoronary fat volume but not attenuation differentiates culprit lesions in patients with myocardial infarction. Atherosclerosis. 2018;276:182-188. doi: https://doi.org/10.1016/j.atherosclerosis.2018.05.035
42. Mancio J, Azevedo D, Saraiva F, et al. Epicardial adipose tissue volume assessed by computed tomography and coronary artery disease: a systematic review and meta-analysis. Eur Hear J — Cardiovasc Imaging. 2018;19(5):490-497. doi: https://doi.org/10.1093/ehjci/jex314
43. Hassan M, Said K, Rizk H, et al. Segmental peri-coronary epicardial adipose tissue volume and coronary plaque characteristics. Eur Hear J – Cardiovasc Imaging. 2016;17(10):1169-1177. doi: https://doi.org/10.1093/ehjci/jev298
44. Sequeira DI, Ebert LC, Flach PM, et al. The correlation of epicardial adipose tissue on postmortem CT with coronary artery stenosis as determined by autopsy. Forensic Sci Med Pathol. 2015;11(2):186-192. doi: https://doi.org/10.1007/s12024-015-9659-7
45. Douglass E, Greif S, Frishman WH. Epicardial Fat. Cardiol Rev. 2017;25(5):230-235. doi: https://doi.org/10.1097/CRD.0000000000000153
46. Oliveros E, Somers VK, Sochor O, et al. The Concept of Normal Weight Obesity. Prog Cardiovasc Dis. 2014;56(4):426-433. doi: https://doi.org/10.1016/j.pcad.2013.10.003
47. Wong C, Ganesan AN, Selvanayagam JB. Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions. European Heart Journal. 2017;38(17):1294-1302. doi: https://doi.org/10.1093/eurheartj/ehw045
48. Ding J, Hsu FC, Harris TB, et al. The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J ClinNutr. 2009;90(3):499-504. doi: https://doi.org/10.3945/ajcn.2008.27358
49. Christensen RH, von Scholten BJ, Hansen CS, et al. Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes. CardiovascDiabetol. 2019;18:114. doi: https://doi.org/10.1186/s12933-019-0917-y
50. D’Marco LG, Bellasi A, Kim S, et al. Epicardial adipose tissue predicts mortality in incident hemodialysis patients: a substudy of the Renagel in New Dialysis trial. Nephrol Dial Transplant. 2013;28(10):2586-2595. doi: https://doi.org/10.1093/ndt/gft264
51. Chu C-Y, Lee W-H, Hsu P-C, et al. Association of Increased Epicardial Adipose Tissue Thickness With Adverse Cardiovascular Outcomes in Patients With Atrial Fibrillation. Medicine (Baltimore). 2016;95(11):e2874. doi: https://doi.org/10.1097/MD.0000000000002874
52. Wolff L, Bos D, Murad SD, et al. Liver fat is related to cardiovascular risk factors and subclinical vascular disease: the Rotterdam Study. Eur Hear J – Cardiovasc Imaging. 2016;17(12):1361-1367. doi: https://doi.org/10.1093/ehjci/jew174
53. Manolopoulos KN, Karpe F, Frayn KN. Gluteofemoral body fat as a determinant of metabolic health. Int J Obes. 2010;34(6):949-959. doi: https://doi.org/10.1038/ijo.2009.286
54. Yusuf S, Hawken S, Ôunpuu S, et al. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study. Lancet. 2005;366(9497):1640-1649. doi: https://doi.org/10.1016/S0140-6736(05)67663-5
55. Gupta A, Pandey A, Ayers C, et al. An Analysis of Individual Body Fat Depots and Risk of Developing Cancer. Mayo Clin Proc. 2017;92(4):536-543. doi: https://doi.org/10.1016/j.mayocp.2016.12.023
56. Ibrahim MM. Subcutaneous and visceral adipose tissue: Structural and functional differences. Obes Rev. 2010. doi: https://doi.org/10.1111/j.1467-789X.2009.00623.x
Supplementary files
Review
For citations:
Miklishanskaya S.V., Mazur N.A. Types of obesity and their impact on long-term outcomes in patients with cardiovascular disease. Obesity and metabolism. 2021;18(2):125-131. (In Russ.) https://doi.org/10.14341/omet12367
Views:
6191
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
